Covered recipient · General Payments record
RIHAM M WAHBA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$783.68
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $510.00 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $181.11 | 12 |
| PFIZER INC. | $65.80 | 2 |
| Corcept Therapeutics | $40.28 | 2 |
| Merck Sharp & Dohme Corporation | $39.62 | 2 |
| Lilly USA, LLC | $36.95 | 2 |
| Novo Nordisk AS | $35.89 | 2 |
| Phathom Pharmaceuticals, Inc. | $25.45 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.04 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.89 | 1 |
| E.R. Squibb & Sons, L.L.C. | $16.17 | 1 |
| Exact Sciences Corporation | $14.99 | 1 |
| GlaxoSmithKline, LLC. | $14.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $19.65 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711907 | CMS |
| Amgen Inc. | $6.33 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711909 | CMS |
| Amgen Inc. | $23.70 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711911 | CMS |
| Amgen Inc. | $6.00 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711913 | CMS |
| Amgen Inc. | $24.17 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711915 | CMS |
| Amgen Inc. | $7.60 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711917 | CMS |
| Amgen Inc. | $7.61 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711919 | CMS |
| Amgen Inc. | $21.87 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711921 | CMS |
| Amgen Inc. | $21.96 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711923 | CMS |
| Amgen Inc. | $4.80 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711925 | CMS |
| Amgen Inc. | $15.46 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711927 | CMS |
| Amgen Inc. | $21.96 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711929 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.04 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118145902 | CMS |
| Corcept Therapeutics | $22.54 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117754988 | CMS |
| Corcept Therapeutics | $17.74 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117755076 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.17 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101612261 | CMS |
| Exact Sciences Corporation | $14.99 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114943571 | CMS |
| GlaxoSmithKline, LLC. | $14.81 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115855351 | CMS |
| Lilly USA, LLC | $18.63 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135358290 | CMS |
| Lilly USA, LLC | $18.32 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135368176 | CMS |
| Merck Sharp & Dohme LLC | $15.19 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141744897 | CMS |
| Merck Sharp & Dohme LLC | $24.43 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141884191 | CMS |
| Novartis Pharmaceuticals Corporation | $16.89 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087370772 | CMS |
| Novo Nordisk Inc | $20.56 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097238048 | CMS |
| Novo Nordisk Inc | $15.33 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096892831 | CMS |
| PFIZER INC. | $26.25 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131491544 | CMS |
| PFIZER INC. | $39.55 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131849659 | CMS |
| Phathom Pharmaceuticals, Inc. | $25.45 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151137143 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.